Vaccines and Other Immunizing Agents in the Child and Adolescent Immunization Schedule*
How to use the schedule
To make vaccination recommendations, healthcare providers should:
- Determine recommended vaccine by age (Table 1 - By Age)
- Determine recommended interval for catch-up vaccination (Table 2 - Catch-up)
- Assess need for additional recommended vaccines by medical condition or other indication (Table 3 - By Medical Indication)
- Review vaccine types, frequencies, intervals, and considerations for special situations (Notes)
- Review contraindications and precautions for vaccine types (Appendix)
- Review new or updated ACIP guidance (Addendum)
New Vaccines and Other Immunizing Agents added to the Schedule* (See Addendum)
| Monoclonal antibody | Abbreviation(s) | Trade name(s) |
|---|---|---|
| Respiratory syncytial virus monoclonal antibody (Nirsevimab) | RSV-mAb | Beyfortus™ |
| Vaccines | Abbreviation(s) | Trade name(s) |
|---|---|---|
| COVID-19† | 1vCOV-mRNA | Comirnaty®/Pfizer- BioNTech COVID-19 Vaccine |
| Spikevax®/Moderna COVID-19 Vaccine | ||
| 1vCOV-aPS | Novavax COVID-19 Vaccine | |
| Dengue vaccine | DEN4CYD | Dengvaxia® |
| Diphtheria, tetanus, and acellular pertussis vaccine | DTaP | Daptacel® Infanrix® |
| Haemophilus influenzae type B vaccine | Hib (PRP-T) | ActHIB® Hiberix® |
| Hib (PRP-OMP) | PedvaxHIB® | |
| Hepatitis A vaccine | HepA | Havrix® Vaqta® |
| Hepatitis B vaccine | HepB | Engerix-B® Recombivax HB® |
| Human papillomavirus vaccine | HPV | Gardasil 9® |
| Influenza vaccine (inactivated) | IIV4 | Multiple |
| Influenza vaccine (live, attenuated) | LAIV4 | FluMist® Quadrivalent |
| Measles, mumps, and rubella vaccine | MMR | M-M-R II® Priorix® |
| Meningococcal serogroups A, C, W, Y vaccine | MenACWY-CRM | Menveo® |
| MenACWY-TT | MenQuadfi® | |
| Meningococcal serogroup B vaccine | MenB-4C | Bexsero® |
| MenB-FHbp | Trumenba® | |
| Meningococcal serogroup A, B, C, W, Y vaccine | MenACWY-TT/MenB-FHbp | Penbraya™ |
| Mpox vaccine | Mpox | Jynneos® |
| Pneumococcal conjugate vaccine | PCV15 | Vaxneuvance™ |
| PCV20 | Prevnar 20® | |
| Pneumococcal polysaccharide vaccine | PPSV23 | Pneumovax 23® |
| Poliovirus vaccine (inactivated) | IPV | Ipol® |
| Respiratory syncytial virus vaccine | RSV | Abrysvo™ |
| Rotavirus vaccine | RV1 RV5 |
Rotarix® RotaTeq® |
| Tetanus, diphtheria, and acellular pertussis vaccine | Tdap | Adacel® Boostrix® |
| Tetanus and diphtheria vaccine | Td | Tenivac® TDvax™ |
| Varicella vaccine | VAR | Varivax® |
Combination vaccines (use combination vaccines instead of separate injections when appropriate)
(Use combination vaccines instead of separate injections when appropriate)
| Vaccines | Abbreviation(s) | Trade name(s) |
|---|---|---|
| DTaP, hepatitis B, and inactivated poliovirus vaccine | DTaP-HepB-IPV | Pediarix® |
| DTaP, inactivated poliovirus, and Haemophilus influenzae type B vaccine | DTaP-IPV/Hib | Pentacel® |
| DTaP and inactivated poliovirus vaccine | DTaP-IPV | Kinrix® Quadracel® |
| DTaP, inactivated poliovirus, Haemophilus influenzae type b, and hepatitis B vaccine | DTaP-IPV-Hib-HepB | Vaxelis® |
| Measles, mumps, rubella, and varicella vaccines | MMRV | ProQuad® |
*Administer recommended vaccines if immunization history is incomplete or unknown. Do not restart or add doses to vaccine series for extended intervals between doses. When a vaccine is not administered at the recommended age, administer at a subsequent visit. The use of trade names is for identification purposes only and does not imply endorsement by the ACIP or CDC.